Launch of sister journal: Kidney CancerInvestigating the predictive impact of the proliferation biomarker Ki-67The synergistic relationship between immunotherapy and radiation.Pathologic substagingGenerating the muscle invasive bladder cancer interactome.Expression status of hypoxia related markers in bladder cancer tissue.

We are pleased to announce the launch this month of a new sister journal to Bladder Cancer – introducing: Kidney Cancer. Find out more at the journal website, where the inaugural issue is openly available.

Investigating the impact of the proliferation biomarker Ki-67 in initial stage pTa urothelial carcinoma of the bladder. Examples of low (<10%, A) and strong (≥50%, B) staining of Ki-67 under 5 fold and 40 fold magnification. From: Breyer, et al., Bladder Cancer, vol. 3, no. 3, pp. 173-180, 2017

The synergistic relationship between immunotherapy and radiation. 
From Buchwald and Efstathiou. Bladder Cancer, vol. 1, no. 1, pp. 15-27,

Pathologic substaging – pT1c denotes tumor invasion below the muscularis mucosae but above the muscularis propria.
From: Gershman et al., Bladder Cancer, vol. 2, no. 1, pp. 1-14, 2016

Generating the muscle invasive bladder cancer interactome.
From: Bhat et al., Bladder Cancer, vol. 2, no. 1, pp. 65-76, 2016

Expression status of hypoxia related markers in bladder cancer tissue.  Immunohistochemistry staining of HIF1a, CA-IX, GLUT-1 and Ki-67 in paraffin-embedded TMA sections of bladder cancer tissues. 
From: Boström et al., Bladder Cancer, vol. 2, no. 1, pp. 101-109, 2016

Welcome to Bladder Cancer

Paper Alert

Between 15 and 20% of patients with newly diagnosed urothelial cancer (UC) of the bladder will have high grade (HG) non-muscle invasive (NMI) disease including...

In 2014, I was on the Board of Directors of the Society of Urologic Oncology (SUO) when Merck announced having shortages of Tice strain Bacillus...

The standard initial treatment for urothelial cancer and other tumors of the bladder is a complete transurethral resection (TURBT). This is, of course, also a...

Paper Alert

Between 15 and 20% of patients with newly diagnosed urothelial cancer (UC) of the bladder will have high grade (HG) non-muscle invasive (NMI) disease including...

In 2014, I was on the Board of Directors of the Society of Urologic Oncology (SUO) when Merck announced having shortages of Tice strain Bacillus...

No front page content has been created yet.